3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Prostatic Neoplasms
10
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
3
Glioma
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Brain Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Ependymoma
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Ureteral Neoplasms
1
Thyroid Nodule
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Tacrolimus
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Melphalan
3
Cyclophosphamide
3
Busulfan
3
Biopsy
3
fludarabine
2
Patient Reported Outcome Measures
2
Mesna
2
Colposcopy
2
Aminolevulinic Acid
2
tirbanibulin
1
ruxolitinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Thalidomide
1
Tamoxifen
1
Sirolimus
1
Robotic Surgical Procedures
1
Radiotherapy, Intensity-Modulated
1
Pregnancy Tests
1
Nivolumab
1
Methotrexate
1
Immunohistochemistry
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precancerous Conditions
×
Watchful Waiting
×
1 year
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled